The necessity of therapeutic approaches focused on the inflammatory microenvironment of colorectal cancer (CRC) is becoming more and more apparent, both in order to improve post-surgical care and subsequent therapeutic strategies, and also for better quality of life for the patients. We have investigated a panel of 39 inflammatory factors using a multiplex magnetic bead-based immunoassay, in relation with CEA and CA19-9, classical tumor markers and the expression levels of pErk, occludin, and STAT1 and STAT3 transcriptional factors. Within the tumor and paired normal tissue samples collected during tumor resection surgery, we have identified 32 biomarkers displaying statistically significant differences. Several relevant correlations have been observed in a combined multi-type correlation matrix. Chitinase 3-like 1 seems to be a trigger for activation pathways for tumor growth and metastasis. Through IL-22 and IL1β, IL-8 correlates indirectly with CA19-9 and CEA, respectively. We also emphasize the diminished APRIL and high BAFF levels in colon cancer tumor tissue, which is quite unique. The strong correlation between APRIL, BAFF, IL-8 and MMP2 recommends these as combined targets in immunotherapies for colon cancer treatment, and indicates the marker quartet may serve as a starting point in colon cancer screening.